LightPath Technologies Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results
Science

LightPath Technologies Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results

Robust Demand for Germanium-Free Optics Drives Meaningful Backlog Growth with Defense and Public Safety Customers

ORLANDO, Fla., Sept. 25, 2025 /PRNewswire/ — LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” “we,” or “our”), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal 2025 fourth quarter and full year ended June 30, 2025.

Financial Summary:



Three Months Ended

June 30,



Year Ended

June 30,


$ in millions


2025



2024



%
Change



2025



2024



%
Change


Revenue


$

12.2



$

8.6




41.4

%


$

37.6



$

31.7




17.3

%

Gross Profit


$

2.7



$

2.5




6.6

%


$

10.1



$

8.6




17.4

%

Operating Expenses


$

7.2



$

4.7




52.0

%


$

22.0



$

16.5




33.4

%

Net Income (Loss)


$

(7.1)



$

(2.4)




-199.8

%


$

(14.9)



$

(8.0)




-85.7

%

Adjusted EBITDA* (non-GAAP)


$

(2.0)



$

(1.1)




-77.1

%


$

(5.1)



$

(2.8)




-83.8

%

Fourth Quarter Fiscal 2025 & Subsequent Highlights: 

  • Announced $18.2 million purchase order for infrared (“IR”) cameras from a leading global technology customer expected to be delivered in CY 2026, and a follow-on $22.1 million purchase order for a second tranche expected to be delivered in CY 2027.
  • Secured $8.0 million strategic investment from Ondas Holdings and Unusual Machines to support LightPath’s continued growth and leadership as a provider of IR imaging solutions to the growing drone/UAV sector.
  • Commenced production of two high-end cooled IR camera products, redesigned from our subsidiary, G5 Infrared, LLC’s (“G5”) original design to utilize LightPath’s Proprietary BlackDiamond™ Glass in place of Germanium.
  • G5 launched its first industrial-grade mid-wave IR (“MWIR”) optical gas imaging (“OGI”) camera alongside a successful test at a certified facility, validating its performance in-line with the U.S. EPA guidelines.
  • Awarded an initial $2.2 million engineering development model (“EDM”) order for IR cameras by L3Harris Technologies to support the Navy’s Shipboard Panoramic Electro-Optic/Infrared (SPEIR) Program.
  • Secured an aggregate of $9.7 million in orders for cooled IR cameras with an existing defense customer for counter UAV applications, for planned delivery in fiscal 2026.
  • Participated in leading industry and investor conferences including the Canaccord 45th Annual Growth Conference, Photonics Spectra Infrared Imaging Summit 2025, SPIE Defense + Commercial Sensing, and the 2025 Border Security Expo.

Management Commentary

Sam Rubin, Chief Executive Officer of LightPath, said: “Fiscal 2025 closed with a clear validation of our strategy: move away from Germanium optics, scale our proprietary BlackDiamond™ glass into key defense verticals, and push up the value chain into complete IR camera systems. Supply chain risk and Chinese critical mineral export restrictions are accelerating customer demand for Germanium alternatives, pushing them to our in-house BlackDiamond™ solution. As we look back on the last few months, execution clearly matched the thesis with strong order growth, reflected by an intense customer desire for secure supply chains amid growing geopolitical uncertainty.

“Earlier this month, we booked an initial $18.2 million IR camera order from a leading global technology customer, with a follow-on $22.1 million purchase order placed two weeks later. On the defense side, in the quarter we also secured a $2.2 million engineering development model order from L3Harris for the Navy’s SPEIR program and added a $9.7 million cooled-camera orders for counter UAS applications with an existing defense customer, reinforcing our traction in programs of record across shipboard surveillance, border security, and counter-UAS.

“On the product innovation front, we launched our first industrial-grade MWIR OGI camera and validated performance at a certified facility in line with EPA processes – broadening our OGI portfolio alongside our low-cost LWIR uncooled offering. Most notably, we are actively redesigning G5’s product line to implement our proprietary BlackDiamond™ material in place of Germanium, driven by intense customer demand for more secure supply chains following China’s Germanium export restrictions. To that end, we recently announced the first two camera redesigns that now utilize our materials instead of Germanium.

“We continue to solidify our place as a vertically-integrated imaging solutions provider – combining proprietary BlackDiamond™ materials and advanced manufacturing to deliver differentiated systems with higher ASPs and better margin potential. The Germanium-free redesigns reduce supply chain risk and shorten time-to-field, while our broadened camera portfolio expands our reachable market in both defense and industrial customer bases. We are now focused on scaling deliveries and converting a robust pipeline, including expected near-term follow-ons and additional program awards, into sustainable revenue growth through fiscal 2026 and beyond. The path forward is straightforward – continue to convert the market’s Germanium supply chain angst into BlackDiamond™-based camera sales – moving up the value chain with a focus on building sustainable, long-term value for my fellow stockholders,” concluded Rubin.

Fourth Quarter Fiscal 2025 Financial Results

Revenue for the fourth quarter of fiscal 2025 increased 41.4% to $12.2 million, compared to $8.6 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company’s product groups in the fourth quarter of fiscal 2025 as follows:

Product Group Revenue

($ in millions)**


Fourth Quarter
of

Fiscal 2025



Fourth Quarter
of

Fiscal 2024



% Change


Infrared Components


$

4.9



$

3.0




63

%

Visible Components


$

2.8



$

3.2




-11

%

Assemblies & Modules


$

4.2



$

1.4




203

%

Engineering Services


$

0.3



$

1.0




-75

%

** Numbers may not foot due to rounding

Gross profit increased 6.6% to $2.7 million, or 22.0% of total revenues, in the fourth quarter of 2025, as compared to $2.5 million, or 29.2% of total revenues, in the same quarter of the prior fiscal year. The difference in gross margin as a percentage of revenue was primarily due to an approximately $0.5 million increase in inventory reserve charges recorded in the fourth quarter of fiscal 2025, primarily attributable to visible components.

Operating expenses increased 52.0% to $7.2 million for the fourth quarter of fiscal 2025, as compared to $4.7 million in the same quarter of the prior fiscal year. The increase was primarily due to: (i) the integration of G5 following its acquisition earlier this year, as well as increased sales and marketing spend to promote new products; (ii) an increase in materials spend for internally-funded new product development projects; and (iii) an increase in the fair value of acquisition liabilities of $1.4 million. The earnout liability for the G5 acquisition will continue to be adjusted until it is paid out.

Net loss in the fourth quarter of fiscal 2025 totaled $7.1 million, or $0.16 per basic and diluted share, as compared to $2.4 million, or $0.06 per basic and diluted share, in the same quarter of the prior fiscal year. The change in net loss was primarily driven by an increase in certain non-cash, non-operating expenses associated with the G5 acquisition and the related financing.

Adjusted EBITDA* loss for the fourth quarter of fiscal 2025 was $2.0 million, compared to a loss of $1.1 million for the same period of the prior fiscal year.

Fiscal 2025 Financial Results

Revenue for fiscal 2025 increased 17.4% to $37.2 million, compared to $31.7 million in the prior fiscal year. Revenue was split amongst the Company’s product groups in fiscal 2025 as follows:

Product Group Revenue

($ in millions)**


Fiscal
2025



Fiscal
2024



%
Change


Infrared Components


$

14.3



$

14.1




2

%

Visible Components


$

11.7



$

11.2




4

%

Assemblies & Modules


$

8.0



$

4.5




79

%

Engineering Services


$

3.2



$

2.0




63

%

** Numbers may not foot due to rounding

Gross profit increased 17.4% to $10.1 million, or 27.2% of total revenues, in fiscal 2025, as compared to $8.6 million, or 27.2% of total revenues, in the prior fiscal year. Gross margin as a percentage of revenue was favorably impacted in fiscal 2025 by product mix, with more revenue from assemblies and modules and engineering services, which typically have higher margins than IR components, and unfavorably impacted by an approximately $0.5 million increase in inventory reserve charges primarily related to visible components.

Operating expenses increased 33.4% to $22.0 million for fiscal 2025, as compared to $16.5 million in the prior fiscal year. The increase was due to: (i) higher legal and consulting fees related to business development and strategic initiatives, including expenses associated with the G5 acquisition, as well as increased sales and marketing spend to promote new products; (ii) an increase in materials spend for internally funded new product development projects; and (iii) an increase in the fair value of acquisition liabilities of $1.4 million.

Net loss in fiscal 2025 totaled $14.9 million, or $0.36 per basic and diluted share, as compared to $8.0, or $0.21 per basic and diluted share, in the prior fiscal year. The change in net loss was driven by an increase in certain non-cash, non-operating expenses associated with the G5 acquisition and the related financing.

Adjusted EBITDA* loss for fiscal 2025 was $5.1 million, compared to a loss of $2.8 million for the prior fiscal year.

Fourth Quarter Fiscal 2025 Earnings Call

Management will host an investor conference call at 5:00 p.m. Eastern time today, September 25, 2025, to discuss the Company’s fourth quarter and year end fiscal 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Q4 FY2025 Earnings Conference Call 
Date: Thursday, September 25, 2025
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13749942
Webcast: LPTH Q4 FY2025 Earnings Conference Call

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Thursday, October 9, 2025. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 13749942. A webcast replay will also be available using the webcast link above.

About LightPath Technologies

LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath’s family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials – sold under exclusive license from the U.S. Naval Research Laboratory – to complete IR optical systems and thermal imaging assemblies. The Company’s primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.

*Use of Non-GAAP Financial Measures 

To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes: (1) the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to the warrants; and (2) the loss on extinguishment of debt. The fair value of the warrants is re-measured each reporting period until the warrants are either exercised or expired (which expiration occurs on February 18, 2031).

A “non-GAAP financial measure” is generally defined as a numerical measure of a company’s historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company’s management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.

LIGHTPATH TECHNOLOGIES, INC.

Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure




(unaudited)




Three Months Ended June 30,



Year Ended June 30,




2025



2024



2025



2024


Net loss


$

(7,055,980)



$

(2,353,773)



$

(14,873,182)



$

(8,007,346)


Depreciation and amortization



792,488




1,062,559




4,149,240




4,048,409


Income tax provision



(122,402)




(53,912)




37,790




67,490


Interest expense



312,967




42,814




1,118,213




191,862


EBITDA


$

(6,072,927)



$

(1,302,312)



$

(9,567,939)



$

(3,699,585)


Stock-based compensation



298,309




216,765




1,043,464




1,019,023


Loss on extinguishment of debt









418,502





Change in fair value of warrant liability



2,224,270







1,353,716





Change in fair value of acquisition liabilities



1,430,000







1,560,445





Foreign exchange (gain) loss



141,583




(31,876)




129,882




(72,741)


Adjusted EBITDA


$

(1,978,765)



$

(1,117,423)



$

(5,061,930)



$

(2,753,303)


% of revenue



-16

%



-13

%



-14

%



-9

%

Forward-Looking Statements

This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “guidance,” “plan,” “estimate,” “will,” “would,” “project,” “maintain,” “intend,” “expect,” “anticipate,” “prospect,” “strategy,” “future,” “likely,” “may,” “should,” “believe,” “continue,” “opportunity,” “potential,” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding: (i) expected purchase orders and anticipated timing for program awards, as well as any resulting impact on our financial performance; (ii) the impact of the G5 acquisition on our business and results of operations, including with respect to the Company’s ability to redesign G5’s product line; (iii) the performance of our product portfolio and expected market potential with our products as well as expected demand for Germanium-free products; (iv) our ability to generate sustainable revenue growth through 2026 and beyond while also building stockholder value; (v) expectations regarding our ability to secure government and military projects with certain customers; and (vi) our ability to manage supply chain risk. These forward-looking statements are based on information available at the time the statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the likelihood that the Company will need additional capital to sustain its operations in the future and to repay indebtedness; the impact of varying demand for the Company products; the Company’s reliance on a few key customers; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to internal customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas/ Israel war; the effects of steps that the Company could take to reduce operating costs; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets

(unaudited)




June 30,



June 30,


Assets


2025



2024


Current assets:







Cash and cash equivalents


$

4,877,036



$

3,480,268


Trade accounts receivable, net of allowance of $24,495 and $25,676



9,455,310




4,928,931


Inventories, net



12,858,838




6,551,059


Prepaid expenses and deposits



1,142,661




445,900


Other current assets



40,150




131,177


Total current assets



28,373,995




15,537,335











Property and equipment, net



15,864,061




15,210,612


Operating lease right-of-use assets



7,429,378




6,741,549


Intangible assets, net



15,987,923




3,650,739


Goodwill



13,753,921




6,764,127


Deferred tax assets, net



22,571




123,000


Other assets



73,917




59,602


Total assets


$

81,505,766



$

48,086,964


Liabilities and Stockholders’ Equity









Current liabilities:









Accounts payable


$

7,421,430



$

3,231,713


Accrued liabilities



5,686,396




1,911,867


Accrued payroll and benefits



2,359,152




1,446,452


Operating lease liabilities, current



1,254,062




1,059,998


Loans payable, current portion



172,567




209,170


Finance lease obligation, current portion



206,518




177,148


Total current liabilities



17,100,125




8,036,348











Deferred tax liabilities, net



152,760




326,197


Accrued liabilities, noncurrent



823,000




611,619


Finance lease obligation, less current portion



421,363




528,753


Operating lease liabilities, noncurrent



8,326,250




8,058,502


Loans payable, less current portion



4,804,990




325,880


Total liabilities



31,628,488




17,887,299











Commitments and Contingencies


















Series G Convertible Preferred Stock; $0.01 par value


$

34,232,510














Stockholders’ equity:









Preferred stock: Series D, $.01 par value, voting; 500,000 shares authorized; none issued and outstanding







Common stock: Class A, $.01 par value, voting; 94,500,000 shares authorized; 42,949,307 and 39,254,643 shares issued and outstanding



429,493




392,546


Additional paid-in capital



244,953,346




245,140,758


Accumulated other comprehensive income



978,686




509,936


Accumulated deficit



(230,716,757)




(215,843,575)


Total stockholders’ equity



15,644,768




30,199,665


Total liabilities, convertible preferred stock and stockholders’ equity


$

81,505,766



$

48,086,964


LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(unaudited)




Three Months Ended



Year Ended




June 30,



June 30,




2025



2024



2025



2024


Revenue, net


$

12,209,793



$

8,634,132



$

37,202,630



$

31,726,192


Cost of sales



9,519,040




6,109,100




27,072,516




23,094,946


Gross profit



2,690,753




2,525,032




10,130,114




8,631,246


Operating expenses:

















Selling, general and administrative



4,739,622




3,605,988




15,814,627




12,297,383


New product development



1,064,997




582,822




3,063,772




2,400,420


Amortization of intangible assets



(54,695)




434,403




1,414,817




1,635,523


Change in fair value of acquisition liabilities



1,430,000







1,560,445





Loss on disposal of property and equipment



18,829




111,336




99,334




124,584


Total operating expenses



7,198,753




4,734,549




21,952,995




16,457,910


Operating loss



(4,508,000)




(2,209,517)




(11,822,881)




(7,826,664)


Other income (expense):

















Interest expense, net



(312,967)




(42,814)




(1,118,213)




(191,862)


Loss on extinguishment of debt









(418,502)





Change in fair value of warrant liability



(2,224,270)







(1,353,716)





Other income (expense), net



(133,145)




(155,354)




(122,080)




78,670


Total other income (expense), net



(2,670,382)




(198,168)




(3,012,511)




(113,192)


Loss before income taxes



(7,178,382)




(2,407,685)




(14,835,392)




(7,939,856)


Income tax provision



(122,402)




(53,912)




37,790




67,490


Net loss


$

(7,055,980)



$

(2,353,773)



$

(14,873,182)



$

(8,007,346)


Foreign currency translation adjustment



527,619




(119,009)




468,750




(96,600)


Comprehensive loss


$

(6,528,361)



$

(2,472,782)



$

(14,404,432)



$

(8,103,946)


Loss per common share (basic)


$

(0.16)



$

(0.06)



$

(0.36)



$

(0.21)


Number of shares used in per share calculation (basic)



42,874,607




38,850,526




40,874,068




37,944,935


Loss per common share (diluted)


$

(0.16)



$

(0.06)



$

(0.36)



$

(0.21)


Number of shares used in per share calculation (diluted)



42,874,607




38,850,526




40,874,068




37,944,935


LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited)




Temporary Equity












Accumulated










Series G Convertible



Class A



Additional



Other






Total




Preferred Stock



Common Stock



Paid-in



Comprehensive



Accumulated



Stockholders’




Shares



Amount



Shares



Amount



Capital



Income



Deficit



Equity


Balances at June 30, 2023









37,344,739



$

373,447



$

242,808,771



$

606,536



$

(207,836,229)



$

35,952,525


Issuance of common stock for:































Employee Stock Purchase Plan









30,447




304




39,373










39,677


Exercise of stock options, RSUs & RSAs, net









945,188




9,452




(9,452)











Issuance of common stock under public equity placement









585,483




5,855




800,477










806,332


Issuance of common stock for acquisition of Visimid









348,786




3,488




482,566










486,054


Stock-based compensation on stock options, RSUs & RSAs















1,019,023










1,019,023


Foreign currency translation adjustment


















(96,600)







(96,600)


Net loss





















(8,007,346)




(8,007,346)


Balances at June 30, 2024









39,254,643




392,546




245,140,758




509,936




(215,843,575)




30,199,665


Issuance of preferred stock under private equity placement, net of fees



24,956




19,481,376




















Issuance of common stock for:

































Employee Stock Purchase Plan









9,369




93




14,292










14,385


Exercise of stock options, RSUs & RSAs, net









593,791




5,938




(2,763)










3,175


Shares issued as compensation









49,000




490




89,180










89,670


Issuance of common stock for acquisition of Visimid









382,253




3,823




710,123










713,946


Issuance of common stock for acquisition of G5









1,972,501




19,725




4,852,343










4,872,068


Issuance of common stock under private equity placement, net of fees









687,750




6,878




1,584,014










1,590,892


Issuance of warrants under private equity placement, net of fees















177,445










177,445


Preferred cumulative dividends plus accretion






14,751,134










(14,751,134)










(14,751,134)


Stock-based compensation on stock options, RSUs & RSAs















953,795










953,795


Reclassification of warrant liability















6,185,293










6,185,293


Foreign currency translation adjustment


















468,750








468,750


Net loss





















(14,873,182)




(14,873,182)


Balances at June 30, 2025



24,956



$

34,232,510




42,949,307



$

429,493



$

244,953,346



$

978,686



$

(230,716,757)



$

15,644,768


LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)




Year Ended June 30,




2025



2024


Cash flows from operating activities:







Net loss


$

(14,873,182)



$

(8,007,346)


Adjustments to reconcile net loss to net cash (used in) provided by operating activities:









Depreciation and amortization



4,149,240




4,048,409


Interest from amortization of loan issuance costs



213,829





Loss on extinguishment of debt



71,215





Warrant issuance costs



418,502





Change in fair value of warrant liability



1,353,716





Change in fair value of warrant liability



1,560,445





Loss on disposal of property and equipment



94,860




124,584


Stock-based compensation on stock options, RSUs & RSAs, net



1,043,464




1,019,023


Provision for credit losses



(3,014)




(4,426)


Change in operating lease assets and liabilities



(273,624)




183,393


Inventory write-offs to allowance



143,362




136,676


Deferred taxes



(221,977)




(121,803)


Changes in operating assets and liabilities, net of acquisitions:









Trade accounts receivable



(2,626,267)




1,498,698


Other current assets



91,027




(131,177)


Inventories



(1,385,690)




960,739


Prepaid expenses and deposits



(325,915)




133,810


Accounts payable and accrued liabilities



2,238,619




680,457


Net cash (used in) provided by operating activities



(8,331,390)




521,037











Cash flows from investing activities:









Purchase of property and equipment



(1,262,302)




(2,182,805)


Proceeds from sale of equipment



10,648





Proceeds from sale-leaseback of equipment






364,710


Acquisition of G5



(18,486,669)





Acquisition of Visimid, net of cash acquired






(847,141)


Net cash used in investing activities



(19,738,323)




(2,665,236)











Cash flows from financing activities:









Proceeds from exercise of stock options



3,175





Proceeds from sale of common stock from Employee Stock Purchase Plan



14,385




39,677


Proceeds from issuance of common stock under public equity placement






806,332


Proceeds from issuance of common stock under private equity placement



437,725





Proceeds from issuance of preferred stock under private equity placement



18,675,026





Proceeds from issuance of warrants under private equity placement



4,620,561





Deferred payment for acquisition of Visimid



(125,000)





Borrowings on loans payable



6,659,596




278,926


Loan issuance costs



(597,465)





Payments on loans payable



(204,100)




(2,459,474)


Repayment of finance lease obligations



(187,626)




(131,901)


Net cash provided by (used in) financing activities



29,296,277




(1,466,440)


Effect of exchange rate on cash and cash equivalents



170,204




(53,583)


Change in cash, cash equivalents and restricted cash



1,396,768




(3,664,222)


Cash, cash equivalents and restricted cash, beginning of period



3,480,268




7,144,490


Cash, cash equivalents and restricted cash, end of period


$

4,877,036



$

3,480,268











Supplemental disclosure of cash flow information:









Interest paid in cash


$

273,476



$

196,541


Income taxes paid


$

206,121



$

166,858


Supplemental disclosure of non-cash investing & financing activities:









Purchase of equipment through finance lease arrangements


$

93,048



$

396,058


Operating right-of-use assets acquired in exchange for operating lease liabilities





$

92,136


Issuance of common stock for acquisition of Visimid


$

713,946



$

486,054


Issuance of common stock for acquisition of G5


$

4,872,068





Accrual of earnout consideration for acquisition of G5


$

3,536,471





Extinguisment of debt in exchange for common stock, preferred stock, warrants and a note


$

3,057,110





SOURCE LightPath Technologies